AU8072691A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
AU8072691A
AU8072691A AU80726/91A AU8072691A AU8072691A AU 8072691 A AU8072691 A AU 8072691A AU 80726/91 A AU80726/91 A AU 80726/91A AU 8072691 A AU8072691 A AU 8072691A AU 8072691 A AU8072691 A AU 8072691A
Authority
AU
Australia
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80726/91A
Inventor
Edward Stewart Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014354A external-priority patent/GB9014354D0/en
Priority claimed from GB909014364A external-priority patent/GB9014364D0/en
Priority claimed from GB909014367A external-priority patent/GB9014367D0/en
Priority claimed from GB909014365A external-priority patent/GB9014365D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU8072691A publication Critical patent/AU8072691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU80726/91A 1990-06-28 1991-06-20 Pharmaceutical preparations Abandoned AU8072691A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9014354 1990-06-28
GB9014365 1990-06-28
GB9014364 1990-06-28
GB909014354A GB9014354D0 (en) 1990-06-28 1990-06-28 Pharmaceutical preparations
GB909014364A GB9014364D0 (en) 1990-06-28 1990-06-28 Pharmaceutical preparations
GB909014367A GB9014367D0 (en) 1990-06-28 1990-06-28 Pharmaceutical preparations
GB909014365A GB9014365D0 (en) 1990-06-28 1990-06-28 Pharmaceutical preparations
GB9014367 1990-06-28

Publications (1)

Publication Number Publication Date
AU8072691A true AU8072691A (en) 1992-01-23

Family

ID=27450525

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80726/91A Abandoned AU8072691A (en) 1990-06-28 1991-06-20 Pharmaceutical preparations

Country Status (3)

Country Link
AU (1) AU8072691A (en)
IE (1) IE912237A1 (en)
WO (1) WO1992000103A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
DE4314976C1 (en) * 1993-05-06 1994-10-06 Lohmann Therapie Syst Lts Transdermal therapeutic systems for the administration of drugs, process for their production and their use
AU5966196A (en) * 1995-06-08 1997-01-09 Eli Lilly And Company Methods of treating cold and allergic rhinitis
US5990159A (en) * 1996-02-15 1999-11-23 Janssen Pharmaceutica, N.V. Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
EP0999830A1 (en) 1997-07-01 2000-05-17 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
EP1077704A4 (en) * 1998-05-21 2002-01-30 Lilly Co Eli Combination therapy for treatment of depression
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
TWI226829B (en) * 1998-05-22 2005-01-21 Lilly Co Eli Pharmaceutical compositions for treatment of partial responders or refractory depression
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
IL139591A0 (en) * 1998-05-29 2002-02-10 Lilly Co Eli Combination therapy for treatment of bipolar disorders
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
WO2005023767A2 (en) 2003-09-10 2005-03-17 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3872872T2 (en) * 1987-11-14 1993-02-04 Beecham Group Plc 5-HT3 RECEPTOR ANTAGONISTS FOR TREATMENT OF CUSHION AND BRONCHO CONSTRUCTION.

Also Published As

Publication number Publication date
IE912237A1 (en) 1992-01-01
WO1992000103A1 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
AU656157B2 (en) Pharmaceutical agents
AU4243289A (en) Pharmaceutical formulations
IL139235A0 (en) Pharmaceutical preparations
AU5681294A (en) Tastemasked pharmaceutical materials
AU3888793A (en) Novel medicament
AU8118391A (en) Shampoo system
AU2954692A (en) Medical preparations
AU8072691A (en) Pharmaceutical preparations
AU7358591A (en) Lipopeptide derivatives
AU9044091A (en) Pharmaceuticals
AU1189392A (en) Pharmaceutical agent
AU2493792A (en) Pharmaceutical preparation
AU6236090A (en) Pharmaceutical preparations
AU6012990A (en) Pharmaceutical formulation
AU2065588A (en) Pharmaceutical preparations for external use
AUPM855194A0 (en) Controlled-release pharmaceutical preparations
GB8906129D0 (en) Pharmaceutical preparations
AU4758190A (en) Pharmaceutical preparation
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
AU5050490A (en) Human monocyte-macrophage-csf preparations
AU5653790A (en) Cosmetic preparations
AU1103092A (en) Immunopotentiating drug
AU7135091A (en) Pharmaceutical composition
GB9014364D0 (en) Pharmaceutical preparations
GB9014365D0 (en) Pharmaceutical preparations